Israel-based CytoReason, which uses AI to develop disease models, raised $80M from Nvidia, Pfizer, Thermo Fisher, and OurCrowd, and plans a Massachusetts office (Steven Scheer/Reuters)

Steven Scheer / Reuters:
Israel-based CytoReason, which uses AI to develop disease models, raised $80M from Nvidia, Pfizer, Thermo Fisher, and OurCrowd, and plans a Massachusetts office  —  Israel's CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.